John Cox, Director at REPLIGEN CORP (RGEN), sold 3,716 shares at $96.72 ($359K) on 2020-03-24, disclosed to the SEC on 2020-03-26.
Open-market sale of $359k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.72 | 1,858 | $180K | 50.0% |
| 2 | $96.72 | 1,858 | $180K | 50.0% |
| Total | $96.72 avg | 3,716 | $359K | 100% |
| Filing → |
| DYN | SELL | 2026-06-17 | $49K | — | Filing → |
| DYN | SELL | 2026-05-14 | $61K | — | Filing → |
| DYN | SELL | 2026-03-06 | $41K | — | Filing → |